Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

This is a study for people with colon, pancreatic, Squamous Non-small cell lung cancer, or Squamous cell carcinoma of head and neck. In this study, we want to find out if an investigational drug (Tisotumab Vedotin) is effective for people with solid tumors.

This is a research study for people diagnosed with AML. The purpose of this study is to see if the treatment of a combination of two drugs (cytarabine liposome therapy) and adding a third drug (pomalidomide) in different doses is more effective.

If you have been diagnosed with melanoma and need surgery to remove it, you may be able to take part in a research study. In this study, we want to learn whether a smaller incision during melanoma surgery is better or worse than the usual standard of care.

The purpose of this study is to look at the effectiveness of a combination of treatments, polatuzumab vedotin with rituximab, gemcitabine, dexamethasone, and cisplatin (PV-RGDP) at treating relapsed or refractory diffuse large B-cell lymphoma.

Do you have a type of cancer known as Nonseminmatous Germ Cell Tumor (NSGCT)? Has your cancer come back, or not get better with the last treatment you received? If so, you may be able to participate in a gene therapy study to see if we can use your body's own immune cells as a treatment for your NSGCT.

Have you been diagnosed with advanced unresectable pancreatic cancer. If so, you may be able to take part in a research study looking at the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer.

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

The purpose of this study is to increase the involvement of black breast cancer patients in clinical research trials and connect these patients with resources.